To further validate the impact of EPAS1 on GBM cell invasiveness in vitro, we first analyzed endogenous EPAS1 expression in a panel of GBM cell lines (U87, U251, and LN229) by Western blotting (Fig. 7A). Here, EPAS1 is linked to glioblastoma.